Apimeds Pharmaceuticals US Prices IPO at $4.00-$5.00 Per Share (APUS)
Apimeds Pharmaceuticals US (APUS) plans to raise $20 million in an initial public offering (IPO) on the week of March 10th, IPO Scoop reports. The company will issue 4,500,000 shares at $4.00-$5.00 per share. The company has a market cap of $57.1 million. D. Boral Capital (ex-EF Hutton) acted as the underwriter for the IPO. […]
Apimeds Pharmaceuticals US (APUS) plans to raise $20 million in an initial public offering (IPO) on the week of March 10th, IPO Scoop reports. The company will issue 4,500,000 shares at $4.00-$5.00 per share. The company has a market cap of $57.1 million. D. Boral Capital (ex-EF Hutton) acted as the underwriter for the IPO. […]
